Literature DB >> 26887

Characterization of alpha- and beta-adrenergic receptors linked to human platelet adenylate cyclase.

K H Jakobs, W Saur, G Schultz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 26887     DOI: 10.1007/BF00508297

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  27 in total

1.  Changes in catecholamine- and glucagon-responsive adenylate cyclase activity in preneoplastic rat liver.

Authors:  H Boyd; T J Martin
Journal:  Mol Pharmacol       Date:  1976-03       Impact factor: 4.436

2.  Assay for adenylate cyclase and cyclic nucleotide phosphodiesterases and the preparation of high specific activity 32-P-labeled substrates.

Authors:  C Nakai; G Brooker
Journal:  Biochim Biophys Acta       Date:  1975-05-23

3.  Studies on the role of cyclic AMP in human lipolysis.

Authors:  T W Burns; P E Langley; G A Robison
Journal:  Adv Cyclic Nucleotide Res       Date:  1972

4.  Stimulation of human platelet adenylate cyclase by prostaglandin D2.

Authors:  D C Mills; D E Macfarlane
Journal:  Thromb Res       Date:  1974-09       Impact factor: 3.944

5.  Platelet aggregation. 3. An epinephrine induced decrease in cyclic AMP synthesis.

Authors:  N R Marquis; J A Becker; R L Vigdahl
Journal:  Biochem Biophys Res Commun       Date:  1970-06-05       Impact factor: 3.575

6.  Adenyl cyclase activity in human platelets.

Authors:  S M Wolfe; N R Shulman
Journal:  Biochem Biophys Res Commun       Date:  1969-04-29       Impact factor: 3.575

7.  Role of cyclic AMP in mediating the effects of MSH, norepinephrine, and melatonin on frog skin color.

Authors:  K Abe; G A Robison; G W Liddle; R W Butcher; W E Nicholson; C E Baird
Journal:  Endocrinology       Date:  1969-10       Impact factor: 4.736

8.  An adrenergic receptor mechanism for the control of cyclic 3'5' adenosine monophosphate synthesis in tissues.

Authors:  J R Turtle; D M Kipnis
Journal:  Biochem Biophys Res Commun       Date:  1967-09-07       Impact factor: 3.575

Review 9.  Adenyl cyclase as an adrenergic receptor.

Authors:  G A Robison; R W Butcher; E W Sutherland
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

10.  Modulation of human platelet adenylate cyclase by prostacyclin (PGX).

Authors:  R R Gorman; S Bunting; O V Miller
Journal:  Prostaglandins       Date:  1977-03
View more
  19 in total

1.  Effects of three beta-blockers with different pharmacodynamic properties on platelet aggregation and platelet and plasma cyclic AMP.

Authors:  K Winther; J Trap-Jensen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Subcellular distribution of alpha 2-adrenergic receptors, pertussis-toxin substrate and adenylate cyclase in human platelets.

Authors:  M A Zamorski; J C Ferraro; R R Neubig
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

3.  Agonistic and antagonistic effects of various alpha-adrenergic agonists in human platelets.

Authors:  P Lasch; K H Jakobs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-03       Impact factor: 3.000

4.  [3H] Dihydroergonine binding to alpha-adrenergic receptors in human platelets.

Authors:  K H Jakobs; R Rauschek
Journal:  Klin Wochenschr       Date:  1978

5.  Effects of alpha 2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human platelets.

Authors:  K A Clare; M C Scrutton; N T Thompson
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

6.  Inhibition of adrenaline-induced platelet aggregation by the alpha-adrenoceptor blocking drug benextramine.

Authors:  B Belleau; B G Benfey; C Melchiorre; M Montambault
Journal:  Br J Pharmacol       Date:  1982-06       Impact factor: 8.739

7.  Different inhibitory effect of adrenaline on platelet adenylate cyclase in the presence of GTP plus cholera toxin and of stable GTP analogues.

Authors:  K H Jakobs; G Schultz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

8.  Influence of vasodilators used in the therapy of heart failure on platelet aggregation.

Authors:  B Pfister; P Imhof
Journal:  Agents Actions       Date:  1979-06

9.  Interaction of selective alpha-adrenoceptor agonists and antagonists with human and rabbit blood platelets.

Authors:  J A Grant; M C Scrutton
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

10.  Platelet beta-adrenoceptors.

Authors:  R Kerry; M C Scrutton
Journal:  Br J Pharmacol       Date:  1983-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.